Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares Russell Top 200 Value ETF
IWX
$3.98B
| $4.45M | ﹤0.01% |
68,467
-1,155
| -2% | -$73.7K |
|
2302
Tradeweb Markets
TW
$21.4B
| $4.44M | ﹤0.01% |
68,340
-10,636
| -13% | -$625K |
|
2303
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
| $4.43M | ﹤0.01% |
92,354
-117,411
| -56% | -$5.62M |
|
2304
State Street SPDR S&P Retail ETF
XRT
$449M
| $4.42M | ﹤0.01% |
73,160
+13,389
| +22% | +$831K |
|
|
PRO
2305
DELISTED
PROS Holdings
PRO
| $4.41M | ﹤0.01% |
181,872
-220
| -0.1% | -$5.39K |
|
2306
Abercrombie & Fitch
ANF
$4.42B
| $4.41M | ﹤0.01% |
192,495
-8,105
| -4% | -$160K |
|
2307
Zentalis Pharmaceuticals
ZNTL
$337M
| $4.41M | ﹤0.01% |
218,964
+34,515
| +19% | +$742K |
|
|
ETV
2308
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
| $4.4M | ﹤0.01% |
357,162
-82,082
| -19% | -$1.08M |
|
2309
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
| $4.39M | ﹤0.01% |
486,789
+11,861
| +2% | +$105K |
|
2310
First Trust STOXX European Select Dividend Income Fund
FDD
$891M
| $4.38M | ﹤0.01% |
386,088
-249,683
| -39% | -$2.67M |
|
2311
First Merchants
FRME
$2.68B
| $4.38M | ﹤0.01% |
106,494
-495
| -0.5% | -$20.9K |
|
2312
Palomar
PLMR
$3.55B
| $4.38M | ﹤0.01% |
96,966
-5,151
| -5% | -$351K |
|
2313
Koppers
KOP
$943M
| $4.38M | ﹤0.01% |
155,168
-23,310
| -13% | -$629K |
|
2314
Atara Biotherapeutics
ATRA
$75.5M
| $4.38M | ﹤0.01% |
53,337
+18,434
| +53% | +$1.92M |
|
2315
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$287M
| $4.37M | ﹤0.01% |
162,220
-13,771
| -8% | -$398K |
|
2316
Baidu
BIDU
$37.7B
| $4.37M | ﹤0.01% |
38,182
-25,469
| -40% | -$2.6M |
|
2317
COPT Defense Properties
CDP
$4.3B
| $4.36M | ﹤0.01% |
168,157
-6,549
| -4% | -$168K |
|
2318
i3 Verticals
IIIV
$412M
| $4.36M | ﹤0.01% |
179,261
-861
| -0.5% | -$19.4K |
|
2319
FirstCash
FCFS
$8.85B
| $4.36M | ﹤0.01% |
50,139
-1,053
| -2% | -$93.3K |
|
2320
National Beverage
FIZZ
$2.96B
| $4.35M | ﹤0.01% |
93,549
-4,099
| -4% | -$192K |
|
2321
PLAYSTUDIOS Inc
MYPS
$77.9M
| $4.35M | ﹤0.01% |
1,120,766
-12,222
| -1% | -$49K |
|
2322
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.26B
| $4.35M | ﹤0.01% |
208,953
+39,195
| +23% | +$808K |
|
2323
VanEck Short High Yield Muni ETF
SHYD
$451M
| $4.34M | ﹤0.01% |
194,806
-6,413
| -3% | -$141K |
|
|
REVG
2324
DELISTED
REV Group
REVG
| $4.33M | ﹤0.01% |
343,543
-12,916
| -4% | -$170K |
|
|
RVNC
2325
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.33M | ﹤0.01% |
234,269
+66,207
| +39% | +$1.51M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.